Research and Society

In Germany, around 1.8 million people are affected by dementia (most of them have Alzheimer's), yet this topic plays far too small a role in society - and people with dementia far too often feel that they have to hide themselves and their condition. To this day, dementia is - quite unjustifiably - tainted with shame.

That is why the DZNE Foundation's "German Dementia Aid" endowment fund wants to give the topic of dementia a public stage and call for solidarity with people with dementia. This is the purpose of the #bademantelchallenge campaign: for a life without dementia.MORE

Every two years the Hartwig Piepenbrock-DZNE Prize honors outstanding contributions to the study of neurodegenerative diseases. The Prize is endowed by the Piepenbrock Group and awarded in remembrance of its former Chief Executive Officer and Chairman. Hartwig Piepenbrock himself passed away after suffering from dementia. He had been committed to art, science and society for many years. MORE

The aim of the DZNE Patient Council is to promote awareness of disease-related issues that need to be researched and addressed within the DZNE mission. The Patient Council advises the DZNE Board and DZNE scientists on issues related to the further integration of patients into society and the avoidance of their stigmatization, as well as on health issues that can be improved through medical interventions or care approaches. MORE

As of today, 1.8 million Germans, mostly elderly, are affected by dementia and about 250,000 by Parkinson's disease. Unfortunately, since effective therapies to slow or reverse the progression of either disease are still not really available, the majority of these patients will die from it. MORE

The mechanisms of neurodegeneration are still puzzling in many respects – so far, there is no cure. In view of this, we aim to lay the groundwork for better treatments and medicines for humans by deciphering the molecular and cellular processes that trigger and are associated with neuronal damage. MORE